Wiedemer Nancy L, Harden Paul S, Arndt Isabelle O, Gallagher Rollin M
Philadelphia VA Medical Center, Philadelphia, Pennsylvania 19104, USA.
Pain Med. 2007 Oct-Nov;8(7):573-84. doi: 10.1111/j.1526-4637.2006.00254.x.
To measure the impact of a structured opioid renewal program for chronic pain run by a nurse practitioner (NP) and clinical pharmacist in a primary care setting.
Patients with chronic noncancer pain managed with opioid therapy in a primary care clinic staffed by 19 providers serving 50,000 patients at an urban academic Veterans hospital.
Naturalistic prospective outcome study.
Based on published opioid prescribing guidelines and focus groups with primary care providers (PCPs), a structured program, the Opioid Renewal Clinic (ORC), was designed to support PCPs managing patients with chronic noncancer pain requiring opioids. After training in the use of opioid treatment agreements (OTAs) and random urine drug testing (UDT), PCPs worked with a pharmacist-run prescription management clinic supported by an onsite pain NP who was backed by a multi-specialty Pain Team. After 2 years, the program was evaluated for its impact on PCP practice and satisfaction, patient adherence, and pharmacy cost.
A total of 335 patients were referred to the ORC. Of the 171 (51%) with documented aberrant behaviors, 77 (45%) adhered to the OTA and resolved their aberrant behaviors, 65 (38%) self-discharged, 22 (13%) were referred for addiction treatment, and seven (4%) with consistently negative UDT were weaned from opioids. The 164 (49%) who were referred for complexity including history of substance abuse or need for opioid rotation or titration, with no documented aberrant drug-related behaviors, continued to adhere to the OTA. Use of UDT and OTAs by PCPs increased. Significant pharmacy cost savings were demonstrated.
An NP/clinical pharmacist-run clinic, supported by a multi-specialty team, can successfully support a primary care practice in managing opioids in complex chronic pain patients.
评估由一名执业护士(NP)和临床药剂师在基层医疗环境中开展的结构化阿片类药物续方项目的影响。
在一家城市学术性退伍军人医院的基层医疗诊所中,接受阿片类药物治疗的慢性非癌性疼痛患者。该诊所由19名医疗服务提供者组成,为50000名患者提供服务。
自然前瞻性结局研究。
基于已发表的阿片类药物处方指南以及与基层医疗提供者(PCP)的焦点小组讨论,设计了一个结构化项目——阿片类药物续方诊所(ORC),以支持PCP管理需要阿片类药物的慢性非癌性疼痛患者。在接受阿片类药物治疗协议(OTA)使用和随机尿液药物检测(UDT)培训后,PCP与一个由药剂师管理的处方管理诊所合作,该诊所由一名现场疼痛NP提供支持,该NP得到了一个多专科疼痛团队的支持。两年后,对该项目对PCP实践和满意度、患者依从性以及药房成本的影响进行了评估。
共有335名患者被转诊至ORC。在171名(51%)有记录的异常行为患者中,77名(45%)遵守了OTA并解决了他们的异常行为,65名(38%)自行出院,22名(13%)被转诊接受成瘾治疗,7名(4%)UDT结果持续为阴性的患者逐渐停用了阿片类药物。164名(49%)因包括药物滥用史或需要阿片类药物轮换或滴定等复杂性问题而被转诊且无记录的异常药物相关行为的患者,继续遵守OTA。PCP对UDT和OTA的使用增加。药房成本显著节省。
由多专科团队支持的NP/临床药剂师管理诊所能够成功支持基层医疗实践对复杂慢性疼痛患者的阿片类药物管理。